Citations for
1ACCPN, SLC12A6
De novo variants in SLC12A6 cause sporadic early-onset progressive sensorimotor neuropathy
Park J, Flores BR, Scherer K, Kuepper H, Rossi M, Rupprich K, Rautenberg M, Deininger N, Weichselbaum A, Grimm A, Sturm M, Grasshoff U, Delpire E, Haack TB.
J Med Genet. Apr;57(4):283-288. doi: 10.1136/jmedgenet-2019-106273. Epub 2019 Aug 22. 2020
2ACCPN, SLC12a6
A Novel Splice-Site Variant in SLC12A6 Causes Andermann Syndrome without Agenesis of the Corpus Callosum
Al Shibli N, Al-Maawali A, Elmanzalawy A, Al-Nabhani M, Koul R, Gabr A, Al Murshedi F.
J Pediatr Genet. Dec;9(4):293-295. doi: 10.1055/s-0039-1700975. Epub 2020 Jan 6. 2020
3ACCPN, SLC12A6
KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent neuromuscular junction defects.
Bowerman M, Salsac C, Bernard V, Soulard C, Dionne A, Coque E, Benlefki S, Hince P, Dion PA, Butler-Browne G, Camu W, Bouchard JP, Delpire E, Rouleau GA, Raoul C, Scamps F.
Neurobiol Dis. Oct;106:35-48. doi: 10.1016/j.nbd.2017.06.013. Epub 2017 Jun 21 2017
4ACCPN, SLC12A6
HMSN/ACC truncation mutations disrupt brain-type creatine kinase-dependant activation of K+/Cl- co-transporter 3.
Salin-Cantegrel A, Shekarabi M, Holbert S, Dion P, Rochefort D, Laganière J, Dacal S, Hince P, Karemera L, Gaspar C, Lapointe JY, Rouleau GA.
Hum Mol Genet 17(17):2703-11. Epub 2008 Jun 19. 2008
5ACCPN, SLC12A6
Distal truncation of KCC3 in non-French Canadian HMSN/ACC families.
Salin-Cantegrel A, Rivière JB, Dupré N, Charron FM, Shekarabi M, Karéméra L, Gaspar C, Horst J, Tekin M, Deda G, Krause A, Lippert MM, Willemsen MA, Jarrar R, Lapointe JY, Rouleau GA.
Neurology 69(13):1350-5.PMID: 17893295 2007
6SLC12A6, ACCPN
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome.
Uyanik G, Elcioglu N, Penzien J, Gross C, Yilmaz Y, Olmez A, Demir E, Wahl D, Scheglmann K, Winner B, Bogdahn U, Topaloglu H, Hehr U, Winkler J.
Neurology 66(7):1044-8. Erratum in: Neurology. 2006 Oct 24;67(8):1528. 2006
7ACCPN, SLC12A6
Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold.
Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ, Faulhaber J, Ehmke H, Pfeffer C, Scheel O, Lemcke B, Horst J, Leuwer R, Pape HC, Volkl H, Hubner CA, Jentsch TJ.
EMBO J 22(20):5422-34. 2003
8ACCPN
Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population.
Howard HC, Dube MP, Prevost C, Bouchard JP, Mathieu J, Rouleau GA.
Eur J Hum Genet 10(7):406-12. 2002
9ACCPN, SLC12A6
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.
Howard HC, Mount DB, Rochefort D, Byun N, Dupre N, Lu J, Fan X, Song L, Riviere JB, Prevost C, Horst J, Simonati A, Lemcke B, Welch R, England R, Zhan FQ, Mercado A, Siesser WB, George AL Jr, McDonald MP, Bouchard JP, Mathieu J, Delpire E, Rouleau GA.
Nat Genet 32(3):384-92. 2002
10ACCPN
The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q.
Casaubon LK, et al.
Am J Hum Genet 58 : 28-34. 1996